Rx Roundup: Quiz of the Week — April 12, 2024

April 12, 2024

By Lauren Biscaldi, MS

Quiz

Article

Test your pharmacy news knowledge with our weekly quiz.

Did you get your fill of pharmacy news this week? Take the Rx Roundup quiz of the week and test your knowledge about the latest stories published by the Drug Topics team from April 8 to April 12.

Approximately how many children in the United States are currently living with asthma?

Newsletter

Pharmacy practice is always changing. Stay ahead of the curve with the Drug Topics newsletter and get the latest drug information, industry trends, and patient care tips.

Recent Videos

Related Content

Pharmacist-Led Interventions Show Promise in Improving COPD Outcomes

Pharmacist-Led Interventions Show Promise in Improving COPD Outcomes

Brian Nowosielski

Researchers conducted a review of pharmacist interventions and their ability to impact the outcomes of patients with COPD.

Over the Counter podcast

Episode 8: Stay in Sync with Innovations in Medication Decision Support

Drug Topics staff

August 6th 2020

Episode 8 of Over the Counter discusses the new and exciting modernizations in the medication decision support space.

FDA to Evaluate Merck’s Doravirine, Islatravir Regimen for HIV-1

FDA to Evaluate Merck’s Doravirine, Islatravir Regimen for HIV-1

The FDA set a Prescription Drug User Fee Act (PDUFA) date of April 28, 2026.

FDA Approves Sebetralstat for Hereditary Angioedema

FDA Approves Sebetralstat for Hereditary Angioedema

The therapy is now the first and only oral on demand treatment option for the condition.

Increased COVID-19 Testing Skewed Understanding of Respiratory Disease Trends

Increased COVID-19 Testing Skewed Understanding of Respiratory Disease Trends

Brian Nowosielski

Researchers determined the impact COVID-19 interventions had on Danish children’s incidence of RSV, influenza, and invasive pneumococcal disease.

FDA Approves Belimumab Autoinjection for Patients 5 and Older With Active Lupus Nephritis

FDA Approves Belimumab Autoinjection for Patients 5 and Older With Active Lupus Nephritis

Ashley Gallagher

This approval offers pediatric patients and caregivers the first subcutaneous option that can be administered at home.

Related Content

Pharmacist-Led Interventions Show Promise in Improving COPD Outcomes

Pharmacist-Led Interventions Show Promise in Improving COPD Outcomes

Brian Nowosielski

Researchers conducted a review of pharmacist interventions and their ability to impact the outcomes of patients with COPD.

Over the Counter podcast

Episode 8: Stay in Sync with Innovations in Medication Decision Support

Drug Topics staff

August 6th 2020

Episode 8 of Over the Counter discusses the new and exciting modernizations in the medication decision support space.

FDA to Evaluate Merck’s Doravirine, Islatravir Regimen for HIV-1

FDA to Evaluate Merck’s Doravirine, Islatravir Regimen for HIV-1

The FDA set a Prescription Drug User Fee Act (PDUFA) date of April 28, 2026.

FDA Approves Sebetralstat for Hereditary Angioedema

FDA Approves Sebetralstat for Hereditary Angioedema

The therapy is now the first and only oral on demand treatment option for the condition.

Increased COVID-19 Testing Skewed Understanding of Respiratory Disease Trends

Increased COVID-19 Testing Skewed Understanding of Respiratory Disease Trends

Brian Nowosielski

Researchers determined the impact COVID-19 interventions had on Danish children’s incidence of RSV, influenza, and invasive pneumococcal disease.

FDA Approves Belimumab Autoinjection for Patients 5 and Older With Active Lupus Nephritis

FDA Approves Belimumab Autoinjection for Patients 5 and Older With Active Lupus Nephritis

Ashley Gallagher

This approval offers pediatric patients and caregivers the first subcutaneous option that can be administered at home.

Editorial Board

Terms and Conditions

Do Not Sell My Personal Information

Contact Info

2 Commerce Drive
Cranbury, NJ 08512

© 2025 MJH Life Sciences

All rights reserved.